Gabriella Ngang, of Farmington Hills, is one of three in Michigan to take part in a clinical trial of a new sickle cell ...

Sickle cell disease is one of the most common genetic blood disorders in the world. It affects millions globally, with the ...

Five NY research centers form Empire State Cellular Therapy Consortium to accelerate cell therapy access for patients.

Around 2,500 people are living with sickle cell disease in the Bay State, and they are advocating for a bill that would improve quality of life for all those dealing with the disease.

The gene-editing therapy OTQ923 normalized brain blood flow in 3 sickle cell disease patients, suggesting it may lower stroke ...

Months after announcing an M&A deal with AstraZeneca, EsoBiotec has released the first small slice of data on the cell ...

Vertex Pharmaceuticals’ Casgevy (exagamglogene autotemcel) has continued to show benefits in sickle cell disease (SCD) ...

Sickle cell disease affects about 100,000 people in the U.S., and 90% of patients are Black, according to NIH.

A study by the Centre for Policy Impact in Global Health revealed that over 30 per cent of people with SCD in Nigeria ...

While the exact number of people living with sickle cell disease is not known, it's estimated that 100,000 people have been ...

Rising sickle cell disease in children demands urgent awareness. Early diagnosis, modern therapies, and vigilant care can ...

European Unitary Patent EP4117446 Validated - Lobe Sciences secures patent protection in 17 EU member states for its DHA and egg yolk-based composition designed to manage Sickle Cell Disease.